Magnesium Citrate Saline Laxative - Cherry Flavor

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within ½ to 6 hours of administration.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose. The medication may be administered as a single dose or divided into multiple doses as needed.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period. For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period. For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period. For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this product.

Patients should be advised to consult a physician prior to use if they have any of the following conditions: kidney disease, a magnesium-restricted diet, abdominal pain, nausea, or vomiting. Additionally, individuals who have experienced a sudden change in bowel habits persisting for more than two weeks or who have used a laxative for longer than one week should seek medical advice before using this product.

It is also essential for patients to inform their healthcare provider or pharmacist if they are currently taking any other medications. This product should be administered at least two hours before or after other drugs, as laxatives may influence the efficacy of concurrent medications.

Patients must discontinue use and consult a physician if they experience rectal bleeding or fail to have a bowel movement after using the product, as these symptoms may indicate a serious underlying condition. Pregnant or breastfeeding individuals should seek guidance from a healthcare professional before using this product.

In the event of an overdose, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is advised to consult a doctor before use if there is a history of kidney disease, a magnesium-restricted diet, or if the patient is experiencing abdominal pain, nausea, or vomiting. Additionally, individuals who have noticed a sudden change in bowel habits persisting for more than two weeks or who have used a laxative for longer than one week should seek medical advice prior to use.

Patients are also encouraged to consult a doctor or pharmacist if they are taking any other medications, as this product may interact with other drugs. It is recommended to take this product at least two hours before or after other medications to minimize potential interactions.

In the event of rectal bleeding or failure to have a bowel movement after use, patients should discontinue use and consult a doctor, as these symptoms may indicate a serious underlying condition. Furthermore, pregnant or breastfeeding individuals should seek guidance from a health professional before using this product.

Drug Interactions

The use of this product should be carefully timed in relation to other medications. It is recommended that this product be taken at least 2 hours before or after the administration of other drugs. This precaution is particularly important as laxatives may influence the efficacy of concurrent medications.

Currently, there is no specific information available regarding drug interactions or interactions with laboratory tests. Therefore, healthcare professionals should remain vigilant and monitor patients for any potential effects when this product is used in conjunction with other therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate Saline Laxative - Cherry Flavor (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a maximum of 7 fl oz within a 24-hour period. For children aged 2 to under 6 years, the maximum dosage is 2 to 3 fl oz, with a total limit of 3 fl oz in 24 hours. It is advised that caregivers consult a doctor before administering the product to children under 2 years of age. For comparison, adults and children aged 12 years and older may have a maximum dosage of 10 fl oz in 24 hours.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have a history of kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant for symptoms that may arise from an overdose, although specific symptoms are not detailed in the provided information. The management of an overdose typically involves supportive care and symptomatic treatment, tailored to the individual patient's needs.

It is essential for healthcare providers to remain alert and prepared to implement appropriate management strategies in response to an overdose situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event of an overdose, healthcare providers should instruct patients to seek medical help immediately or contact a Poison Control Center. Patients should be made aware of the signs of overdose and the urgency of obtaining assistance to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46°F to 86°F (8°C to 30°C) to maintain its efficacy and safety. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate Saline Laxative - Cherry Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)